Moshe Yeshurun

3.2k total citations
108 papers, 2.1k citations indexed

About

Moshe Yeshurun is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Moshe Yeshurun has authored 108 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Hematology, 34 papers in Oncology and 18 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Moshe Yeshurun's work include Hematopoietic Stem Cell Transplantation (42 papers), Acute Myeloid Leukemia Research (30 papers) and Acute Lymphoblastic Leukemia research (15 papers). Moshe Yeshurun is often cited by papers focused on Hematopoietic Stem Cell Transplantation (42 papers), Acute Myeloid Leukemia Research (30 papers) and Acute Lymphoblastic Leukemia research (15 papers). Moshe Yeshurun collaborates with scholars based in Israel, United States and France. Moshe Yeshurun's co-authors include Avichai Shimoni, Arnon Nagler, Anat Gafter‐Gvili, Pia Raanani, Izhar Hardan, Abraham Avigdor, Ron Ram, Mical Paul, Ofer Shpilberg and Leonard Leibovici and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Moshe Yeshurun

103 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Moshe Yeshurun Israel	23	1.1k	607	378	345	343	108	2.1k
Seth Eisenberg United States	9	1.2k 1.1×	542 0.9×	304 0.8×	307 0.9×	267 0.8×	39	2.2k
Prakash Satwani United States	28	1.0k 1.0×	550 0.9×	325 0.9×	268 0.8×	453 1.3×	138	2.1k
Ron Ram Israel	26	1.1k 1.1×	695 1.1×	509 1.3×	161 0.5×	388 1.1×	139	2.3k
Bin Cho South Korea	20	737 0.7×	316 0.5×	381 1.0×	202 0.6×	338 1.0×	168	1.7k
Arcangelo Prete Italy	32	1.2k 1.2×	826 1.4×	479 1.3×	365 1.1×	240 0.7×	132	3.0k
Kazuteru Ohashi Japan	27	1.4k 1.3×	448 0.7×	444 1.2×	288 0.8×	227 0.7×	130	2.1k
José L. Díez‐Martín Spain	24	1.3k 1.2×	778 1.3×	316 0.8×	182 0.5×	451 1.3×	180	2.4k
R. Arnold Germany	27	1.2k 1.2×	577 1.0×	420 1.1×	382 1.1×	262 0.8×	108	2.4k
Maura Faraci Italy	26	831 0.8×	695 1.1×	336 0.9×	468 1.4×	163 0.5×	121	2.2k
Morris Kletzel United States	29	974 0.9×	479 0.8×	384 1.0×	392 1.1×	474 1.4×	148	3.1k

Countries citing papers authored by Moshe Yeshurun

Since Specialization

Citations

This map shows the geographic impact of Moshe Yeshurun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moshe Yeshurun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moshe Yeshurun more than expected).

Fields of papers citing papers by Moshe Yeshurun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moshe Yeshurun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moshe Yeshurun. The network helps show where Moshe Yeshurun may publish in the future.

Co-authorship network of co-authors of Moshe Yeshurun

This figure shows the co-authorship network connecting the top 25 collaborators of Moshe Yeshurun. A scholar is included among the top collaborators of Moshe Yeshurun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moshe Yeshurun. Moshe Yeshurun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gurion, Ronit, Pia Raanani, Iuliana Vaxman, et al.. (2024). Role of Autologous Transplant in Newly Diagnosed Multiple Myeloma Patients Treated with Novel Triplets: A Systematic Review and Meta-Analysis. Acta Haematologica. 148(4). 468–476. 2 indexed citations

Goldberg, Idan, Galit Granot, Alona Telerman, et al.. (2023). Extracorporeal photopheresis induces NETosis in neutrophils derived from patients with chronic graft‐vs‐host disease. Journal of Clinical Apheresis. 38(5). 615–621. 2 indexed citations

Yeshurun, Moshe, Liat Shargian, Oren Pasvolsky, et al.. (2023). Infection prevention practices among EBMT hematopoietic cell transplant centers: the EBMT Infectious Disease Working Party survey. Bone Marrow Transplantation. 58(4). 414–423. 7 indexed citations

Shargian, Liat, Odelia Amit, Hanna Bernstine, et al.. (2022). The role of additional chemotherapy prior to autologous HCT in patients with relapse/refractory DLBCL in partial remission—A retrospective multicenter study. European Journal Of Haematology. 110(2). 149–156. 2 indexed citations

Shargian, Liat, Pia Raanani, Moshe Yeshurun, Anat Gafter‐Gvili, & Ronit Gurion. (2022). Chimeric antigen receptor T‐cell therapy is superior to standard of care as second‐line therapy for large B‐cell lymphoma: A systematic review and meta‐analysis. British Journal of Haematology. 198(5). 838–846. 22 indexed citations

Shargian, Liat, Pia Raanani, Moshe Yeshurun, Anat Gafter‐Gvili, & Ronit Gurion. (2022). CAR‐T cell therapy is superior to standard of care as second‐line therapy for large B‐cell lymphoma: A systematic review and meta‐analysis. British Journal of Haematology. 200(1). e4–e5. 6 indexed citations

Ram, Ron, Sigal Grisariu, Liat Shargian, et al.. (2021). A Comprehensive Toxicity and Efficacy Analysis of Different Bridging Therapies Prior to Anti CD19-CAR-T Cell Therapy in Patients with DLBCL- a National Multi-Center Cohort Study. Blood. 138(Supplement 1). 1733–1733.

Shimony, Shai, Moshe Yeshurun, Ofir Wolach, et al.. (2021). Post-transplantation maintenance with sorafenib or midostaurin for FLT3 positive AML patients – a multicenter retrospective observational study. Leukemia & lymphoma. 62(10). 2475–2481. 3 indexed citations

Telerman, Alona, Galit Granot, Moshe Yeshurun, et al.. (2021). Neutrophil Extracellular Traps Are Increased in Chronic Myeloid Leukemia and Are Differentially Affected by Tyrosine Kinase Inhibitors. Cancers. 14(1). 119–119. 17 indexed citations

10.

Pasvolsky, Oren, Liat Shargian, Uri Rozovski, et al.. (2021). Eltrombopag for enhancement of platelet engraftment in patients undergoing allogeneic cord blood transplantation. Leukemia & lymphoma. 62(11). 2747–2754. 5 indexed citations

11.

Pasvolsky, Oren, Shai Shimony, Moshe Yeshurun, et al.. (2021). Maintenance therapy after allogeneic hematopoietic transplant for acute myeloid leukemia: a systematic review and meta-analysis. Acta Oncologica. 60(10). 1335–1341. 12 indexed citations

12.

Shargian, Liat, Ofir Wolach, Uri Rozovski, et al.. (2020). Sequential treatment with FLAG-IDA/treosulfan conditioning regimen for patients with active acute myeloid leukemia. Annals of Hematology. 99(12). 2939–2945. 1 indexed citations

13.

Yeshurun, Moshe, Uri Rozovski, Oren Pasvolsky, et al.. (2020). Efficacy of folinic acid rescue following MTX GVHD prophylaxis: results of a double-blind, randomized, controlled study. Blood Advances. 4(16). 3822–3828. 6 indexed citations

14.

Shargian, Liat, Anat Gafter‐Gvili, Haim Ben‐Zvi, et al.. (2019). Risk factors for mortality due to Acinetobacter baumannii bacteremia in patients with hematological malignancies – a retrospective study. Leukemia & lymphoma. 60(11). 2787–2792. 13 indexed citations

15.

Shargian, Liat, Dafna Yahav, Uri Rozovski, et al.. (2019). Human herpes virus 6 reactivation following autologous hematopoietic cell transplantation – a single-center experience. Leukemia & lymphoma. 60(9). 2230–2236. 3 indexed citations

16.

Rubio, Marie Thérèse, Maud D’Aveni, Myriam Labopin, et al.. (2017). Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party. Journal of Hematology & Oncology. 10(1). 31–31. 28 indexed citations

17.

Muchtar, Eli, Ron Ram, Pia Raanani, et al.. (2014). First line and salvage therapy with total therapy 3-based treatment for multiple myeloma––An extended single center experience. Leukemia Research. 38(12). 1401–1406. 10 indexed citations

18.

Sadan, Ofer, Noam Shemesh, Ran Barzilay, et al.. (2012). Mesenchymal stem cells induced to secrete neurotrophic factors attenuate quinolinic acid toxicity: A potential therapy for Huntington's disease. Experimental Neurology. 234(2). 417–427. 62 indexed citations

19.

Yeshurun, Moshe, L Fouillard, Myriam Labopin, et al.. (2004). A long-term follow-up of 33 patients with non-Hodgkin's lymphoma who received the BEAM high-dose intensification regimen with cytokine support only and no transplant. Leukemia. 18(10). 1717–1721. 3 indexed citations

20.

Yeshurun, Moshe, Jean-Philippe Laporte, Sylvie Lesage, & A Najman. (2002). Spinal Cord Compression of Dual Etiology, Multiple Myeloma and Spinal Tuberculosis. Leukemia & lymphoma. 43(2). 427–428. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact